Core ScientificvsNVIDIA

CORZ and NVDA stock compared: price, dividend, valuation and results, from SEC filings.

NVDA

NVIDIA Corporation

$162.85

Value $3.96T

-2.01%
NVDA's page

Core Scientific (CORZ) has a market value of $4.6B and NVIDIA (NVDA) $3.96T. Over the last year, with dividends, CORZ moved -11.7% and NVDA -15.8%. Dividend yield: CORZ none, NVDA 0.32%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CORZ$4.6B

    NVDA$3.96T

    NVDA is 864 times CORZ

  • Revenue, 12 months

    CORZ$592M

    NVDA$303B

    NVDA is 512 times CORZ

  • Net income, 12 months

    CORZ-$108M

    NVDA$193B

  • Operating margin

    CORZ-73.3%

    NVDA65.2%

    138.5 points apart

  • ROIC

    CORZ-29.6%

    NVDA95.6%

    125.2 points apart

  • P/E

    CORZ–

    NVDA20.5

  • Dividend yield

    CORZ0.0%

    NVDA0.3%

    0.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CORZ-11.7%

NVDA-15.8%

100150DecFebAprJunAugOct
Returns by period
PeriodCORZWith dividendsNVDAWith dividends
1 year since November 12, 2025-11.7%Price -11.7%-15.8%Price -16.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CORZCore ScientificNVDANVIDIA

Valuation

CORZNVDA
Valuation
Price$14.52$162.85
Market value$4.6B$3.96T
Enterprise value (EV)$8.1B$3.93T
P/E–20.5
P/E, 5-year median–49.9
P/B–17.3
EV/EBIT–19.9
Free cash flow yield–3.2%

Results and growth

CORZNVDA
Results and growth
Revenue, 12 months$592M$303B
Net income, 12 months-$108M$193B
Free cash flow, 12 months-$1.3B$127B
Earnings per share, 12 months-$3.31$7.91
Revenue growth, year on year-37.5%65.5%
Revenue growth a year, past+39.5%over 5 years+66.9%over 5 years
EPS growth a year, past–+95.2%over 5 years

Margins and returns on capital

CORZNVDA
Margins and returns on capital
Gross margin41.2%74.7%
Operating margin-73.3%65.2%
Net margin-18.3%63.7%
ROIC-29.6%95.6%
ROE–120.4%

Balance sheet

CORZNVDA
Balance sheet
Cash$804M$56.6B
Total debt$4.4B$38.9B
Net debt / EBITDA–-0.1
Interest cover–426.7×

Dividends and buybacks

CORZNVDA
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$0.52
Dividend growth a year, past–+20.1%over 5 years
Buyback yield–1.0%
Shareholder yield–1.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CORZ or NVDA

Didn't find what you were looking for?

Ask us
Which is bigger, Core Scientific or NVIDIA?

By market value, NVIDIA ($3.96T) is about 864.3 times Core Scientific ($4.6B), at today's prices.

How did CORZ and NVDA stock do over the last 1 years?

Since November 12, 2025, CORZ's price moved -11.7% and NVDA's -16.0%. With dividends: CORZ -11.7% (-11.7% a year), NVDA -15.8% (-15.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, CORZ or NVDA?

The dividend yield at today's price is none for Core Scientific and 0.32% for NVIDIA. Over the last twelve months they paid – and $0.52 per share.

Which has the higher profit margins, Core Scientific or NVIDIA?

Over the last twelve months, the net margin was -18.3% for Core Scientific and 63.7% for NVIDIA, and the operating margin -73.3% and 65.2%. Revenue was $592M and $303B.

Which is the better investment, Core Scientific or NVIDIA?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.